Services
Research & Clinical Development Solutions
Product Development
Regulatory
Clinical
Biometrics
CMC
Technology-Powered Consulting
Management Consulting
Market Access
Patient Engagement
Transaction Advisory
Advanced Analytics
Real-World Evidence
Real-World Evidence
Technology
Health Storylines
A digital platform that puts patients at the center and intersection of human networks, technology, and science
b.research
A single, unified SaaS solution for all EU Phase 4, Real-World Evidence, and Post-Approval studies
b.therapeutics
A platform of do-it-yourself services around the patient, for tracking therapeutic and patient progress
MyReco
A dynamic and empathetic virtual assistant to keep patients motivated so that compliance, retention, and efficiency of trial timelines are maximized
About
Our team
Our team collaborates to fully understand every aspect of each client’s organization from concept ideation to commercial realization, from innovation to implementation
Community involvement
We work with our local and global communities to create positive change through education, service, and sustainable business practices
600+
employees
90+%
has a PhD and/or Masters
15
languages spoken
30
nationalities
Careers
Job openings
Explore our job openings and find the one that is right for you
Why work at Alira Health?
Alira Health is dedicated to providing market-leading professional development, education, travel, and work-life benefits to all team members
Join our team
Join our global team dedicated to innovation and initiative, where physical walls and different time zones don’t limit, but encourage, collaboration
Resources
News
Read all the latest from us
Events
Check out our upcoming events
Publications
Discover our latest industry infographics, articles, white papers, and more
Multimedia
View our videos, podcasts, webinars, and more
Latest in the hub
Alira Health Joins the IRB Barcelona to Advance the Development of Personalized Cancer Treatments
Published: August, 2022
DPHARM
Published: August, 2022
White Paper: New European Health Technology Assessment Regulation
Published: August, 2022
Services
Overview
Research & Clinical Development Solutions
Product Development Regulatory Clinical Biometrics CMC
Technology-Powered Consulting
Management Consulting Market Access Patient Engagement Transaction Advisory Advanced Analytics
Real-World Evidence
Real-World Evidence
Technology
Overview Health Storylines b.research b.therapeutics MyReco
About
Overview Our team Community involvement
Careers
Overview Job openings Why work at Alira Health? Join our team
Resources
Overview News Events Publications Multimedia
Home > Education Hub > Publications
Filtering options
Advanced Analytics
Biometrics
Bordeaux
Business Strategy
CDMO
Clinical
CMC
Crowdfunding
Data Specialist
Decentralized Clinical Trials
Digital Health
Diversity
DPHARM
DTx trends
Due Diligence
European Medicines Agency
France
Genomic Testing
In-Vitro Diagnostic Regulation
Inclusion
Investor Relations
IVDR
Life Sciences
M&A
Market Access
Medical Robotics
MedTech
Orphan Drug
Patient Centric
Patient Centricity
Patient Engagement
Pharma
Rare Disease Trials
Real-World Evidence
Registry-based studies
Regulatory
Research & Development
Robotcs
RWE
Vaccines
All
Publications August 4, 2022
White Paper: New European Health Technology Assessment Regulation
In this white paper, we provide an overview of this new regulation, including key points of the new European Health Technology Assessment Regulation, its methodology, and its timelines.
MedTech Regulatory
Publications August 2, 2022
GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
The last two years have brought forward tremendous advances in the development of prophylactic and therapeutic approaches for the treatment of SARS-CoV-2 infections.
Clinical CMC Vaccines
Publications July 15, 2022
How to leverage registry-based studies to generate high-quality Real-World Evidence
The use of Real-World Evidence (RWE) in regulatory decision making will support the development and application of better medicines.
Real-World Evidence Registry-based studies Regulatory RWE
Publications July 14, 2022
How to successfully use the EMA IRIS portal to ensure timely submissions
Submitting your scientific advice (SA), orphan drug designation (ODD) or Innovation Task Force (ITF) consultation to the EMA? Avoid delays with our submission recommendations.
European Medicines Agency Orphan Drug Regulatory
Publications June 23, 2022
Developing Data Specialist Talent: Collaboration Is Key
Companies across Pharma and MedTech need talented people to cover the range of data-related challenges. Discover what this means for developing talent throughout the industry.
Data Specialist MedTech Pharma
Publications May 27, 2022
The Impact of Chip Shortage on the MedTech Sector and RAS Players
Discover the three factors driving the chip shortage, the impact, and what’s next for Robotic and MedTech industry at large.
CDMO MedTech Robotcs
Publications April 20, 2022
White Paper: Next Generation Therapies: Access, Pricing and Ethical Issues in Perspective
In this white paper, we will explore wide range of new therapies we term “Next Generation Therapies” and challenges related to them.
Market Access
Publications April 8, 2022
Cheat Sheet: MDCG Guidance on Medical Device Classification
Assigning the proper class to a medical device (MD) is one of the most important activities carried out by a manufacturer. Read Alira Health's cheat sheet MDCG Guidance on Medical Device(...)
MedTech Regulatory
Publications March 31, 2022
The FDA’s Project Orbis Can Speed up the Delivery of Your New Oncology Drug to Global Markets
Are you developing an oncology drug? Project Orbis, a program coordinated by the U.S. Food and Drug Administration (FDA), allows you to register your product in several countries with(...)
Pharma Regulatory
Load more

Latest from Alira Health

Events Multimedia News
Events August 10, 2022
DPHARM
We are pleased to announce that we will be sponsoring and attending DPHARM, a unique event focused on the latest innovations that modernize clinical trials.
Clinical Decentralized Clinical Trials DPHARM Patient Centric
Events June 30, 2022
DTx France 2022
We are pleased to announce that we will be joining as speakers and exhibitors at DTx France 2022. This hybrid event will focus on the latest DTx trends, regulatory framework, market(...)
DTx trends Market Access Regulatory
Events June 21, 2022
Advanced Wound Care Summit
Join us at the Advanced Wound Care Summit July 13 – 14 in Boston.
Multimedia August 1, 2022
Partners in the Continuum of Drug Development
Listen to the new Empowered Patient Podcast with Karen Jagoda as Gabriele Brambilla, Alira Health CEO, discusses novel approach using technology services to actively engage and partner(...)
Decentralized Clinical Trials Digital Health Patient Centric
Multimedia July 20, 2022
The Promise and Reality of NGTs
Listen to the episode “The Promise and Reality of Next Generation Therapies".
Market Access
Multimedia July 12, 2022
Webinar Replay: What You Should Know About MDR Best Practices, Including PMCF
Discover the major changes introduced by the MDR, including the post-market requirements, and especially the Post-Market Clinical Follow-up (PMCF).
MedTech Regulatory
News August 17, 2022
Alira Health Joins the IRB Barcelona to Advance the Development of Personalized Cancer Treatments
We are pleased to announce we are joining the Institute for Research in Biomedicine (IRB Barcelona) as part of the CGI-Clinics project.
Patient Centric Real-World Evidence RWE
News June 29, 2022
La société internationale de conseil en santé Alira Health s’implante à Bordeaux
La société Alira Health poursuit son développement en France avec l’ouverture d’un nouveau bureau à Bordeaux.
Bordeaux France
News June 17, 2022
Music Beats Cancer Hosts Reception at BIO International Convention in San Diego
Music Beats Cancer hosted a reception fostering a networking community for innovators working on promising solutions for cancer.
Crowdfunding Patient Centricity Research & Development
View all Events
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.